Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
The updated Covid vaccines should be more accessible, experts say. Saturday 16 September 2023 21:00, Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them ...
The updated doses from Pfizer and Moderna will target KP.2 while the third option, from Novavax, will target JN.1, NBC News reports. ... When should you get the COVID booster? If approved this ...
On Monday, the U.S. Food and Drug Administration approved new mRNA boosters from Moderna and Pfizer. Approval for another booster from Novavax is likely forthcoming. Approval for another booster ...
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
The new Covid boosters appear to work against the BA.2.86 omicron subvariant, Moderna and Pfizer said Wednesday. New Covid boosters work against the highly mutated BA.2.86 variant, vaccine makers ...
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster — to five months rather than six. The two-dose Moderna vaccine is open ...